The Food and Drug Administration conducted surprise inspections of four national compounding pharmacies that uncovered safety and quality issues at each facility just months after contaminated compounded drugs led to a meningitis outbreak that resulted in 48 deaths.
The inspected facilities were: AnazaoHealth Corp. in Tampa, Fla.; Chicago-based Central Admixture Pharmacy Services, also referred to as CAPS; Lee Pharmacy in Fort Smith, Ark.; and Pharmedium Services in Cleveland, Miss. None of the companies immediately responded to requests for comment. The effort is part of the FDA's campaign to conduct proactive investigations into pharmacies that undertake high-risk sterile compounding, said Erica Jefferson, an FDA spokeswoman.